Rockefeller Capital Management L.P.
Position in ORGO — Organogenesis Holdings Inc.
CIK 1739439
NEW YORK, NY
Position in ORGO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,452
-$7,921 QoQ
Shares Held
3,067
-52.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#111
of 134 holders
Holding Since
Sep 2022
5 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rockefeller Capital Management L.P. holds $105,853,317 across 51 Drug Manufacturers - Specialty & Generic names. ORGO ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
373,548 | $62,957,776 | |
| 2 | ZTS |
Zoetis Inc.
|
330,418 | $23,743,834 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
173,438 | $11,091,360 | |
| 4 | HLN |
Haleon plc
|
122,399 | $1,141,981 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
29,716 | $1,030,252 | |
| 6 | VTRS |
Viatris Inc
|
53,630 | $851,642 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
1,506 | $815,994 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
25,940 | $638,382 |
All Filings in ORGO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,452 | 3,067 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $15,373 | 6,487 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $6,739 | 1,301 | Shares | Defined | 2026-03-17 | |
| 2022-12-31 | $102 | 38 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $123 | 38 | Shares | Defined | 2022-11-02 | |
| No filing history on record for this holder in this stock. | ||||||